Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Remetinostat for Basal Cell Carcinoma
NCT03180528Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remetinostat in basal cell carcinoma (BCC). Started Jul 2018; status: completed.
02
Drugs
remetinostat
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT03180528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180528.